comparemela.com

Latest Breaking News On - ஜநெஸிஸ் மருந்து கண்டுபிடிப்பு - Page 1 : comparemela.com

Chutes & Ladders—AltruBio snags new CMO with resume at Sublimity, Ardea, Amgen and Abbott

Chutes & Ladders—AltruBio snags new CMO with resume at Sublimity, Ardea, Amgen and Abbott
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

United-kingdom
British
Matty-culbreth-notaro
Matt-havener
Peter-fekkes
Chan-beals
Vicki-phillos
Leslie-pascaud
Rachel-haverfield
Chan-lee
Norman-lafrance
Kathy-biberstein

Genesis Drug Discovery & Development Appoints Laura Sailor Veteran CRO Business Development Leader As Director Of Business Development.

Genesis Drug Discovery & Development Appoints Laura Sailor Veteran CRO Business Development Leader As Director Of Business Development.
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Wuxi
Jiangsu
China
Olesia-buiakova
Eli-mordechai
Crown-bioscience
Contract-research
Genesis-drug-discovery-development
Genesis-biotechnology-group
Business-development
Icaria-life-sciences
Genesis-drug-discovery

Genesis Drug Discovery and Development Acquires Integrated Analytical Solutions to Add "Off the Shelf" PK Profiling Capabilities to Its Portfolio

Genesis Drug Discovery and Development Acquires Integrated Analytical Solutions to Add Off the Shelf PK Profiling Capabilities to Its Portfolio News provided by Share this article ® (GBG) and its Contract Research Organization (CRO) arm Genesis Drug Discovery & Development™ (GD 3) announced today that it has acquired the Berkeley-based CRO Integrated Analytical Solutions (IAS). Founded in 2004 and located in the San Francisco bay area, IAS is a GxP-compliant CRO providing bioanalytical, drug metabolism, and analytical chemistry services to clients worldwide. Integrated Analytical Solutions (IAS) Logo This is our second acquisition in the space of two months as we further expand our presence in the San Francisco bay area, which we see as a market with tremendous growth potential for drug discovery services said Eli Mordechai, Ph.D., Chief Executive Officer (CEO) of GBG. Adding IAS s GxP compliant bioanalytical platform to GD

San-francisco-bay
California
United-states
Berkeley
Prabal-banerjee
Eli-mordechai
Jonah-michaelian
Ben-bandaru
Contract-research-organization
Analytical-solutions-inc
Corporate-development
Genesis-drug-discovery-development

Genesis Drug Discovery and Development Expands Its Presence in the Clinical Space by Acquiring STATKING Clinical Services

Genesis Drug Discovery and Development Expands Its Presence in the Clinical Space by Acquiring STATKING Clinical Services News provided by Share this article ® (GBG) and its Contract Research Organization (CRO) arm Genesis Drug Discovery & Development™ (GD 3) announced today that it has acquired the Cincinnati-based CRO STATKING Clinical Services. Established in 1989, STATKING provides clinical trial services, including clinical trial management, protocol development, biostatistics, clinical data management, clinical study monitoring, medical writing, medical monitoring, safety reporting, and project management for the regulatory approval of novel drug and medical device products. STATKING Clinical Services We are very pleased to have STATKING join GBG, and this acquisition demonstrates our commitment to making GD

Cincinnati
Ohio
United-states
Prabal-banerjee
Eli-mordechai
Ben-bandaru
Contract-research-organization
Corporate-development
Clinical-services
Genesis-drug-discovery-development
Genesis-biotechnology-group
Business-development

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.